Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis

Victoria K. Baxter, Rebecca Glowinski, Alicia M. Braxton, Michelle C. Potter, Barbara S. Slusher, Diane E. Griffin

Research output: Research - peer-reviewArticle

Abstract

Infection of weanling C57BL/6 mice with the TE strain of Sindbis virus (SINV) causes nonfatal encephalomyelitis associated with hippocampal-based memory impairment that is partially prevented by treatment with 6-diazo-5-oxo-l-norleucine (DON), a glutamine antagonist (Potter et al., J Neurovirol 21:159, 2015). To determine the mechanism(s) of protection, lymph node and central nervous system (CNS) tissues from SINV-infected mice treated daily for 1 week with low (0.3 mg/kg) or high (0.6 mg/kg) dose DON were examined. DON treatment suppressed lymphocyte proliferation in cervical lymph nodes resulting in reduced CNS immune cell infiltration, inflammation, and cell death compared to untreated SINV-infected mice. Production of SINV-specific antibody and interferon-gamma were also impaired by DON treatment with a delay in virus clearance. Cessation of treatment allowed activation of the antiviral immune response and viral clearance, but revived CNS pathology, demonstrating the ability of the immune response to mediate both CNS damage and virus clearance.

LanguageEnglish (US)
Pages134-149
Number of pages16
JournalVirology
Volume508
DOIs
StatePublished - Aug 1 2017

Fingerprint

Sindbis Virus
Alphavirus
Encephalomyelitis
Glutamine
Central Nervous System
Pathology
Viruses
Norleucine
Therapeutics
Lymph Nodes
Diazooxonorleucine
Nerve Tissue
Withholding Treatment
Aptitude
Inbred C57BL Mouse
Interferon-gamma
Antiviral Agents
Cell Death
Lymphocytes
Inflammation

Keywords

  • 6-diazo-5-oxo-l-norleucine
  • Alphavirus encephalomyelitis
  • Glutamate excitotoxicity
  • Immune response
  • Sindbis virus
  • Viral pathogenesis

ASJC Scopus subject areas

  • Virology

Cite this

Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis. / Baxter, Victoria K.; Glowinski, Rebecca; Braxton, Alicia M.; Potter, Michelle C.; Slusher, Barbara S.; Griffin, Diane E.

In: Virology, Vol. 508, 01.08.2017, p. 134-149.

Research output: Research - peer-reviewArticle

@article{9f782eecac2d40abb97d9dd8b9e45838,
title = "Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis",
abstract = "Infection of weanling C57BL/6 mice with the TE strain of Sindbis virus (SINV) causes nonfatal encephalomyelitis associated with hippocampal-based memory impairment that is partially prevented by treatment with 6-diazo-5-oxo-l-norleucine (DON), a glutamine antagonist (Potter et al., J Neurovirol 21:159, 2015). To determine the mechanism(s) of protection, lymph node and central nervous system (CNS) tissues from SINV-infected mice treated daily for 1 week with low (0.3 mg/kg) or high (0.6 mg/kg) dose DON were examined. DON treatment suppressed lymphocyte proliferation in cervical lymph nodes resulting in reduced CNS immune cell infiltration, inflammation, and cell death compared to untreated SINV-infected mice. Production of SINV-specific antibody and interferon-gamma were also impaired by DON treatment with a delay in virus clearance. Cessation of treatment allowed activation of the antiviral immune response and viral clearance, but revived CNS pathology, demonstrating the ability of the immune response to mediate both CNS damage and virus clearance.",
keywords = "6-diazo-5-oxo-l-norleucine, Alphavirus encephalomyelitis, Glutamate excitotoxicity, Immune response, Sindbis virus, Viral pathogenesis",
author = "Baxter, {Victoria K.} and Rebecca Glowinski and Braxton, {Alicia M.} and Potter, {Michelle C.} and Slusher, {Barbara S.} and Griffin, {Diane E.}",
year = "2017",
month = "8",
doi = "10.1016/j.virol.2017.05.013",
volume = "508",
pages = "134--149",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis

AU - Baxter,Victoria K.

AU - Glowinski,Rebecca

AU - Braxton,Alicia M.

AU - Potter,Michelle C.

AU - Slusher,Barbara S.

AU - Griffin,Diane E.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Infection of weanling C57BL/6 mice with the TE strain of Sindbis virus (SINV) causes nonfatal encephalomyelitis associated with hippocampal-based memory impairment that is partially prevented by treatment with 6-diazo-5-oxo-l-norleucine (DON), a glutamine antagonist (Potter et al., J Neurovirol 21:159, 2015). To determine the mechanism(s) of protection, lymph node and central nervous system (CNS) tissues from SINV-infected mice treated daily for 1 week with low (0.3 mg/kg) or high (0.6 mg/kg) dose DON were examined. DON treatment suppressed lymphocyte proliferation in cervical lymph nodes resulting in reduced CNS immune cell infiltration, inflammation, and cell death compared to untreated SINV-infected mice. Production of SINV-specific antibody and interferon-gamma were also impaired by DON treatment with a delay in virus clearance. Cessation of treatment allowed activation of the antiviral immune response and viral clearance, but revived CNS pathology, demonstrating the ability of the immune response to mediate both CNS damage and virus clearance.

AB - Infection of weanling C57BL/6 mice with the TE strain of Sindbis virus (SINV) causes nonfatal encephalomyelitis associated with hippocampal-based memory impairment that is partially prevented by treatment with 6-diazo-5-oxo-l-norleucine (DON), a glutamine antagonist (Potter et al., J Neurovirol 21:159, 2015). To determine the mechanism(s) of protection, lymph node and central nervous system (CNS) tissues from SINV-infected mice treated daily for 1 week with low (0.3 mg/kg) or high (0.6 mg/kg) dose DON were examined. DON treatment suppressed lymphocyte proliferation in cervical lymph nodes resulting in reduced CNS immune cell infiltration, inflammation, and cell death compared to untreated SINV-infected mice. Production of SINV-specific antibody and interferon-gamma were also impaired by DON treatment with a delay in virus clearance. Cessation of treatment allowed activation of the antiviral immune response and viral clearance, but revived CNS pathology, demonstrating the ability of the immune response to mediate both CNS damage and virus clearance.

KW - 6-diazo-5-oxo-l-norleucine

KW - Alphavirus encephalomyelitis

KW - Glutamate excitotoxicity

KW - Immune response

KW - Sindbis virus

KW - Viral pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=85019853293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019853293&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2017.05.013

DO - 10.1016/j.virol.2017.05.013

M3 - Article

VL - 508

SP - 134

EP - 149

JO - Virology

T2 - Virology

JF - Virology

SN - 0042-6822

ER -